Professional Records
License Records
Ngocdiep T Le
License #:
3032708 - Active
Issued Date:
Nov 5, 2003
Expiration Date:
May 2, 2017
Type:
Manicurist Type 3
Ngocdiep Le Phones & Addresses
-
11308 Glen Rd, Potomac, MD 20854 (301) 299-4218
-
Thousand Oaks, CA
-
3 Mapleshade Dr, Whippany, NJ 07981
-
500 Springview Ln, Phoenixville, PA 19460 (610) 935-1056
-
Norristown, PA
-
Durham, NC
-
Anaheim, CA
-
Morristown, NJ
-
Germantown, MD
Work
Company:
Neoimmunetech Feb 2020
Position:
Executive vp, chief medical officer and director of the board
Education
School / High School:
Duke University Medical Center 2015 to 2015
Skills
Oncology • Medicine • Internal Medicine • Clinical Development • Pharmaceutical Industry • Hematology • Clinical Trials • Drug Development • Biotechnology • Biomarkers • Drug Discovery • Cro • Life Sciences • Lifesciences • Gcp • Ctms
Industries
Pharmaceuticals
Resumes
Resumes
Executive Vp, Chief Medical Officer And Director Of The Board
View pageLocation:
Washington, DC
Industry:
Pharmaceuticals
Work:
Neoimmunetech
Executive Vp, Chief Medical Officer and Director of the Board
Verastem Oct 2017 - Oct 2018
Chief Medical Officer
Medimmune Oct 2015 - Jun 2017
Vice President, Oncology Imed
Novartis Oct 2013 - Oct 2015
Executive Director and Global Clinical Program Head
Gsk Jun 2009 - Oct 2013
Senior and Executive Director
Executive Vp, Chief Medical Officer and Director of the Board
Verastem Oct 2017 - Oct 2018
Chief Medical Officer
Medimmune Oct 2015 - Jun 2017
Vice President, Oncology Imed
Novartis Oct 2013 - Oct 2015
Executive Director and Global Clinical Program Head
Gsk Jun 2009 - Oct 2013
Senior and Executive Director
Education:
Duke University Medical Center 2015 - 2015
Duke University Medical Center 2002 - 2006
Duke University Comprehensive Cancer Center 2002 - 2006
Stanford University School of Medicine 1992 - 2000
Doctor of Medicine, Doctorates, Doctor of Philosophy, Biology Caltech 1987 - 1991
Bachelors, Bachelor of Science, Biology
Duke University Medical Center 2002 - 2006
Duke University Comprehensive Cancer Center 2002 - 2006
Stanford University School of Medicine 1992 - 2000
Doctor of Medicine, Doctorates, Doctor of Philosophy, Biology Caltech 1987 - 1991
Bachelors, Bachelor of Science, Biology
Skills:
Oncology
Medicine
Internal Medicine
Clinical Development
Pharmaceutical Industry
Hematology
Clinical Trials
Drug Development
Biotechnology
Biomarkers
Drug Discovery
Cro
Life Sciences
Lifesciences
Gcp
Ctms
Medicine
Internal Medicine
Clinical Development
Pharmaceutical Industry
Hematology
Clinical Trials
Drug Development
Biotechnology
Biomarkers
Drug Discovery
Cro
Life Sciences
Lifesciences
Gcp
Ctms
Publications
Us Patents
Novel Pharmaceutical Composition
View pageUS Patent:
20120183613, Jul 19, 2012
Filed:
Dec 20, 2011
Appl. No.:
13/330949
Inventors:
Douglas J. DeMARINI - Collegeville PA, US
Francisco Henriquez - Collegeville PA, US
Ngocdiep T. LE - Collegeville PA, US
Lihong Wang - Collegeville PA, US
Francisco Henriquez - Collegeville PA, US
Ngocdiep T. LE - Collegeville PA, US
Lihong Wang - Collegeville PA, US
International Classification:
A61K 9/28
A61K 31/519
A61P 35/00
A61K 9/20
A61K 31/519
A61P 35/00
A61K 9/20
US Classification:
424474, 424464, 5142641
Abstract:
Disclosed are novel pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same.
Combination
View pageUS Patent:
20130261075, Oct 3, 2013
Filed:
Dec 20, 2011
Appl. No.:
13/991576
Inventors:
Douglas J. DeMarini - Collegeville PA, US
Ngocdiep T. Le - Collegeville PA, US
Ngocdiep T. Le - Collegeville PA, US
International Classification:
A61K 31/7068
A61K 31/519
A61K 31/519
US Classification:
514 49
Abstract:
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a cancer treatment method that includes administering 4-amino-1-(2-deoxy-2,2-difluoro-β-D-erythro-pentofuranosyl)pyrimidin-2(1H)-on 2′,2′-difluoro-2′-deoxycytidine, or a pharmaceutically acceptable salt thereof, and N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethy;-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, to a human in need thereof.
Novel Pharmaceutical Composition
View pageUS Patent:
20130266649, Oct 10, 2013
Filed:
Dec 20, 2011
Appl. No.:
13/991705
Inventors:
Douglas J. DeMarini - Collegeville PA, US
Ngocdiep T. Le - Collegeville PA, US
Francisco Henriquez - Collegeville PA, US
Lihong Wang - Collegeville PA, US
Ngocdiep T. Le - Collegeville PA, US
Francisco Henriquez - Collegeville PA, US
Lihong Wang - Collegeville PA, US
International Classification:
A61K 31/519
A61J 3/06
A61J 3/10
A61J 3/06
A61J 3/10
US Classification:
424465, 5142641, 264109
Abstract:
Disclosed are novel pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same.
Novel Pharmaceutical Composition
View pageUS Patent:
20140037726, Feb 6, 2014
Filed:
Oct 2, 2013
Appl. No.:
14/044139
Inventors:
Francisco HENRIQUEZ - Collegeville PA, US
Ngocdiep T. LE - Collegeville PA, US
Lihong WANG - Collegeville PA, US
Ngocdiep T. LE - Collegeville PA, US
Lihong WANG - Collegeville PA, US
Assignee:
GlaxoSmithKline LLC - Philadelphia PA
International Classification:
A61K 9/28
A61K 9/20
A61K 31/519
A61K 9/20
A61K 31/519
US Classification:
424465, 5142641
Abstract:
Disclosed are novel pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same.
Novel Pharmaceutical Composition
View pageUS Patent:
20140154316, Jun 5, 2014
Filed:
Dec 11, 2013
Appl. No.:
14/103092
Inventors:
- Brentford, GB
Francisco Henriquez - Collegeville PA, US
Ngocdiep T. Le - Collegeville PA, US
Lihong Wang - Collegeville PA, US
Francisco Henriquez - Collegeville PA, US
Ngocdiep T. Le - Collegeville PA, US
Lihong Wang - Collegeville PA, US
Assignee:
GlaxoSmithKline Intellectual Property (No.2) Limited - Brentford
International Classification:
A61K 9/28
A61K 31/519
A61K 31/519
US Classification:
424465, 544279, 5142641
Abstract:
Disclosed are novel pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same.
Novel Pharmaceutical Composition
View pageUS Patent:
20140099365, Apr 10, 2014
Filed:
Dec 11, 2013
Appl. No.:
14/103193
Inventors:
- Brentford, GB
Francisco Henriquez - Collegeville PA, US
Ngocdiep T. Le - Collegeville PA, US
Lihong Wang - Collegeville PA, US
Francisco Henriquez - Collegeville PA, US
Ngocdiep T. Le - Collegeville PA, US
Lihong Wang - Collegeville PA, US
Assignee:
GlaxoSmithKline Intellectual Property - Brentford
International Classification:
C07D 471/04
A61K 9/20
A61K 9/20
US Classification:
424465, 5142641
Abstract:
Disclosed are novel pharmaceutical compositions containing N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same.